About us
We are a science-led global healthcare company with a purpose to help people do more, feel better and live longer.
At GSK, we are driven by a purpose to help people do more, feel better and live longer.
In India, our long legacy is testament to our commitment and the trust reposed in us over generations.
Working with us means the opportunity to make a life-saving difference in the health of millions of people while enabling you to grow and be the best you can be.
Innovation
Innovation is at the heart of delivering our purpose by using our science to develop pharmaceuticals and vaccines. We invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients and get ahead of disease.
-
2
global R&D centres based in India
-
Fluarix Tetra
GSK's quadrivalent influenza vaccine launched in 2020
-
Nucala
launched in 2019 for protection against exacerbations and oral steroid dependency in severe eosinophilic asthma
-
Menveo
GSK’s quadrivalent Meningococcal Conjugate vaccine, launched in 2019
Performance
We deliver growth by investing effectively in our business, developing our people and executing competitively.
-
#1
in vaccines self-pay segment
-
4
GSK brands among top 50 brands in the Indian pharmaceuticals market (IPM)
-
Over Rs. 3,100 crores
revenue from operations in 2020-21
Trust
We are a responsible company - using our science and technology to address health needs, we are focused on making our products affordable and available and being a modern employer.
-
94%
employee engagement score on our latest employee survey
-
Over 3 billion
tablets donated to to the WHO for ‘Partnering India to Eliminate Lymphatic Filariasis’ since 2001
-
#1
in Access to Medicines Index
Bringing innovative products and improving access to them is critical to helping build stronger, healthier communities. We leverage our legacy of over 90 years in India to help transform people’s health through our extensive product portfolio that includes prescription medicines and vaccines. We are the leaders in anti-infectives and dermatology in the pharmaceuticals industry and in vaccines too we are the leaders in the private segment.
-
1924
GSK started its journey in India and was listed on the National Stock Exchange in 1969
-
#1
We are the market leader in dermatology and in vaccines in the private segment
-
Over Rs. 3,000 crore
turnover (as on 31 March, 2021)
-
Over 3,500 people
work in our advanced manufacturing facility, offices and sales force across India to ensure seamless access of our medicines and vaccines to our patients
What we do
We research, manufacture and make available a broad range of medicines and vaccines that benefit people.
We believe in performance sustainability across all aspects of our business. Our success over the years has depended on several factors including our foray into diverse segments, creating products that people value, making them widely accessible and operating efficiently. Our growth is backed by a strong reputation for genuine care towards patients.

How we do it
Everyone at GSK focuses on 3 priorities - Innovation, Performance, Trust
Find out more
-
Our story
-
India Leadership Team
The ILT manages our activities and each member is responsible for a specific part of the business.
-
Board of Directors
Our board of directors drive the company to constantly work towards delivering results and returns for all stakeholders.
-
Governance
We have the trust of over a million patients and around 100,000 shareholders and we are committed to operating at the highest standards.
-
Our achievements and accolades
Key achievements
-
Policies, codes and standards